4.4 Article

Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function - the Tromso study

Journal

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
Volume 97, Issue 7, Pages 1008-1013

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2011.057653

Keywords

cystatin C; venous thromboembolism; VTE; risk

Categories

Ask authors/readers for more resources

Background Previous studies have shown an association between impaired kidney function, assessed by cystatin C-based estimated glomerular filtration rate, and venous thromboembolism. The aim of this study was to investigate whether serum cystatin C was associated with a risk of venous thromboembolism among subjects with normal kidney function in a prospective population-based study. Design and Methods Cystatin C was measured in serum from 3251 men and women with normal kidney function, aged 25-84 years, who participated in the Tromso study in 1994-1995. Normal kidney function was defined as a creatinine-based estimated glomerular filtration rate greater than 90 mL/min/1.73 m(2) and absence of microalburninuria. Incident venous thromboembolism was registered from the date of inclusion through to the end of follow-up, September 1, 2007. Cox-regression models were used to calculate hazard ratios with 95% confidence intervals for venous thromboembolism. Results There were 83 incident venous thromboembolic events, of which 53 (63.9 %) were provoked, during a median of 12.3 years of follow-up. A one standard deviation (0.11 mg/L) increase in serum cystatin C levels was associated with a 43% (hazard ratio 1.43; 95% confidence interval 1.17-1.72) increased risk of total venous thromboembolism. Subjects with cystatin C levels in the top quartile (<= 0.87 mg/L) had a 2.5-fold (hazard ratio 2.51; 95% confidence interval 1.27-4.96) increased risk of venous thromboembolism compared to those with levels in the bottom quartile (<= 0.72 mg/L) in adjusted analysis. The risk estimates were even higher for provoked venous thromboembolism (hazard ratio 3.11; 95% confidence interval 1.23-7.86). Conclusions Serum cystatin C levels were associated with the risk of venous thromboembolism in subjects with normal kidney function. Our findings suggest that elevated serum cystatin C levels may promote venous thrombosis beyond reflecting impaired kidney function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The TromsO Study

Ludvig B. Rinde, Vania M. Morelli, Birgit Smabrekke, Ellisiv B. Mathiesen, Maja-Lisa Lochen, Inger Njolstad, Tom Wilsgaard, Erin Smith, Frits R. Rosendaal, Kelly A. Frazer, Sigrid K. Braekkan, John-Bjarne Hansen

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

Article Hematology

Cardiorespiratory fitness and future risk of venous thromboembolism

Line H. Evensen, Trond Isaksen, Sigrid K. Braekkan, John-Bjarne Hansen

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

Article Hematology

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism

Benedikte Paulsen, Hanne Skille, Erin N. Smith, Kristian Hveem, Maiken E. Gabrielsen, Sigrid K. Braekkan, Frits R. Rosendaal, Kelly A. Frazer, Olga V. Gran, John-Bjarne Hansen

HAEMATOLOGICA (2020)

Letter Hematology

Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism

Hanne Skille, Benedikte Paulsen, Kristian Hveem, Maiken E. Gabrielsen, Ben Brumpton, Kristian Hindberg, Olga V. Gran, Frits R. Rosendaal, Sigrid K. Braekkan, John-Bjarne Hansen

HAEMATOLOGICA (2020)

Article Hematology

Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism-The Tromso Study

Trond Borvik, Sigrid K. Braekkan, Line H. Evensen, Ellen E. Brodin, Vania M. Morelli, Hasse Melbye, John-Bjarne Hansen

THROMBOSIS AND HAEMOSTASIS (2020)

Review Biochemistry & Molecular Biology

Role of microRNAs in Venous Thromboembolism

Vania M. Morelli, Sigrid K. Braekkan, John-Bjarne Hansen

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Hematology

Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism

Ellen-Sofie Hansen, Kristian Hindberg, Nadezhda Latysheva, Pal Aukrust, Thor Ueland, John-Bjarne Hansen, Sigrid K. Braekkan, Vania M. Morelli

BLOOD (2020)

Article Hematology

Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event

Hanne Skille, Benedikte Paulsen, Kristian Hveem, Maiken E. Gabrielsen, Ben Brumpton, Kristian Hindberg, Olga V. Gran, Frits R. Rosendaal, Sigrid K. Braekkan, John-Bjarne Hansen

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Cell Biology

Platelet count and risk of major bleeding in venous thromboembolism

Hakon S. Johnsen, Sigrid K. Braekkan, Vania M. Morelli, John-Bjarne Hansen

Summary: The study indicates that increasing platelet count in patients with VTE is associated with a higher risk of major bleeding. This association is observed not only with platelet count at VTE diagnosis, but also with platelet count measured on average 7 years before the thrombotic event.

PLATELETS (2021)

Article Hematology

Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism

Hakon S. Johnsen, Esben Bjori, Kristian Hindberg, Sigrid K. Braekkan, Vania M. Morelli, John-Bjarne Hansen

THROMBOSIS RESEARCH (2020)

Article Hematology

D-dimer as a stand-alone test to rule out deep vein thrombosis

Fridtjof B. Rinde, Synne G. Fronas, Waleed Ghanima, Anders Vik, John-Bjarne Hansen, Sigrid K. Braekkan

THROMBOSIS RESEARCH (2020)

Article Hematology

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: The Tromso study

Erin Mathiesen Hald, Maja-Lisa Lochen, Ellisiv B. Mathiesen, Tom Wilsgaard, Inger Njolstad, Sigrid K. Braekkan, John-Bjarne Hansen, Suzanne Cannegieter

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromso Study

Joakim K. Sejrup, Vania M. Morelli, Maja-Lisa Lochen, Inger Njolstad, Ellisiv B. Mathiesen, Tom Wilsgaard, John-Bjarne Hansen, Sigrid K. Braekkan

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism-the Tromso study

Trond Borvik, Line H. Evensen, Vania M. Morelli, Hasse Melbye, Sigrid K. Braekkan, John-Bjarne Hansen

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Dietary intake of marine n-3 polyunsaturated fatty acids and future risk of venous thromboembolism

Trond Isaksen, Line H. Evensen, Stein Harald Johnsen, Bjarne K. Jacobsen, Kristian Hindberg, Sigrid K. Braekkan, John-Bjarne Hansen

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)

No Data Available